US Democratic Senate leaders said on 15 April that they’re backing a national plan to pay manufacturers’ costs to retool existing factories into coronavirus test-making facilities and to share intellectual property (IP) about both rapid tests and serology tests, so many more COVID-19 diagnostics can be created.
The planned legislation – details of which were described by Sens. Chuck Schumer, Debbie Stabenow, and Patty Murray in a...







